Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sytske Anne Bergstra

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Annals of the Rheumatic Diseases|August 22, 2023
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, et al.
Clinical Rheumatology|December 24, 2015
Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritisSytske Anne Bergstra, Iris M Markusse, Gülşah Akdemir, et al.
Rheumatology (Oxford, England)|June 13, 2024
Effect of using the Simple Erosion Narrowing Score or Sharp/van der Heijde score on the power of rheumatoid arthritis clinical trials to detect differences in radiographic progressionNathan den Broeder, Thomas E Bolhuis, Noortje van Herwaarden, et al.
Annals of the Rheumatic Diseases|April 26, 2022
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, et al.
RMD Open|June 5, 2018
Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritisGülşah Akdemir, Iris M Markusse, Sytske Anne Bergstra, et al.
Rheumatology International|January 27, 2022
Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan RegistryAhmed Al Hasan, Floor Reimann, Nic J G M Veeger, et al.
RMD Open|July 15, 2025
Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosisSaad Ahmed, Sophie I E Liem, Jacopo Ciaffi, et al.
Journal of Scleroderma and Related Disorders|February 6, 2023
Mouth opening in systemic sclerosis: Its course over time, determinants and impact on mouth handicapSarah J H Khidir, Maaike Boonstra, Sytske Anne Bergstra, et al.
Seminars in Arthritis and Rheumatism|April 17, 2025
Rheumatoid arthritis-associated interstitial lung disease in countries across the worldSascha L Heckert, Tjardo D Maarseveen, Emiel R Marges, et al.
Pediatric Rheumatology Online Journal|May 10, 2024
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trialBastiaan T van Dijk, Sytske Anne Bergstra, J Merlijn van den Berg, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|August 22, 2023
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, et al.
Clinical Rheumatology|December 24, 2015
Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritisSytske Anne Bergstra, Iris M Markusse, Gülşah Akdemir, et al.
Rheumatology (Oxford, England)|June 13, 2024
Effect of using the Simple Erosion Narrowing Score or Sharp/van der Heijde score on the power of rheumatoid arthritis clinical trials to detect differences in radiographic progressionNathan den Broeder, Thomas E Bolhuis, Noortje van Herwaarden, et al.
Annals of the Rheumatic Diseases|April 26, 2022
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, et al.
RMD Open|June 5, 2018
Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritisGülşah Akdemir, Iris M Markusse, Sytske Anne Bergstra, et al.
Rheumatology International|January 27, 2022
Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan RegistryAhmed Al Hasan, Floor Reimann, Nic J G M Veeger, et al.
RMD Open|July 15, 2025
Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosisSaad Ahmed, Sophie I E Liem, Jacopo Ciaffi, et al.
Journal of Scleroderma and Related Disorders|February 6, 2023
Mouth opening in systemic sclerosis: Its course over time, determinants and impact on mouth handicapSarah J H Khidir, Maaike Boonstra, Sytske Anne Bergstra, et al.
Seminars in Arthritis and Rheumatism|April 17, 2025
Rheumatoid arthritis-associated interstitial lung disease in countries across the worldSascha L Heckert, Tjardo D Maarseveen, Emiel R Marges, et al.
Pediatric Rheumatology Online Journal|May 10, 2024
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trialBastiaan T van Dijk, Sytske Anne Bergstra, J Merlijn van den Berg, et al.
Pageof 6